The company was founded in August 2012 and is a high-tech enterprise focusing on R&D, commercial production and sales of high-end pharmaceutical preparations. The company is committed to the internationalization of pharmaceutical products and provides cost-effective pharmaceutical products to the global market. The company is a chemical pharmaceutical company participating in international competition. The company's main products are sitagliptin metformin extended-release tablets, posaconazole enteric tablets, bupropion hydrochloride extended-release tablets (II), paroxetine hydrochloride enteric sustained-release tablets, sevilam carbonate tablets, ursodeoxycholic acid capsules, etc. Corporate honors: The company has won honors such as “Shanghai Enterprise Technology Center”, “Shanghai Science and Technology Little Giant Enterprise”, “1st Guoxin Cup ESG Golden Bull Award Top 50 Technology Leaders”, and the Shanghai High-tech Achievement Transformation Certificate. It has won honors such as “Jiangsu Specialized and New Small and Medium Enterprises”, “Jiangsu Enterprise Technology Center”, “Advanced Production Safety Unit” in Haimen Development Zone, “Top Ten Pharmaceutical Innovation Service Agencies of the Year”, the “4th Shanghai Intellectual Property Innovation Award Patent Second Prize”, and “Shanghai Patent Work Pilot Enterprise”.